These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1625399)

  • 1. [Leukocyte migration inhibition test in drug-induced pneumonitis].
    Suzuki K; Rahman SG; Akoun GM
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):76-81. PubMed ID: 1625399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study of clinical significance of leukocyte migration inhibition test in drug-induced hypersensitivity pneumonitis].
    Uno K; Kondo A
    Arerugi; 1995 Dec; 44(12):1401-9. PubMed ID: 8871295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity against digestive organ cancers : leucocyte migration inhibitory factor activity as an immunological parameter.
    Hamasaki K
    Acta Med Okayama; 1977 Jun; 31(3):147-59. PubMed ID: 144415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applicability of the leukocyte migration inhibition test in the clinical practice.
    Stanciu L; Dumitrescu D; Radu D
    Med Interne; 1990; 28(4):295-303. PubMed ID: 2100874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukocyte migration inhibition test in agarose: a method for the detection of cellular immunity in humans].
    Alkan SS
    Mikrobiyol Bul; 1976 Oct; 10(4):423-35. PubMed ID: 979705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies of an assay system for dialyzable leukocyte extracts (DLE)--influence of DLE on leukocyte migration inhibition test by HBsAg].
    Hashimoto Y; Sekiguchi S
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):763-8. PubMed ID: 3908264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocyte migration inhibition in amiodarone-associated pneumonitis.
    Akoun GM; Gauthier-Rahman S; Liote HA; Milleron BJ; Mayaud CM
    Chest; 1988 Nov; 94(5):1050-3. PubMed ID: 3053057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A study of clinical significance of leucocyte migration test in drug eruption].
    Abe M; Uno K
    Arerugi; 1998 Dec; 47(12):1264-72. PubMed ID: 10028721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological monitoring in lung cancer: use of the leukocyte migration inhibition assay.
    Abai AM; Fekete B
    Haematologia (Budap); 1982; 15(1):111-25. PubMed ID: 6749608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the pathogenic mechanism of beta-lactam hypersensitivity by the detection of leucocyte migration activating factor and leucocyte migration inhibitory factor].
    Uno K
    Arerugi; 1990 Dec; 39(12):1605-11. PubMed ID: 2096806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cellular immunity: in vitro leukocyte migration inhibition does not correlate with the tuberculin skin test].
    Hofmann E; Sauter C; Reinhardt E
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1376-8. PubMed ID: 482909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test of leukocyte migration inhibition. 1. Value of the test in the diagnosis of certain immune diseases.
    Urcan S; Stanciu L; Georoceanu A; Popescu S
    Med Interne; 1983; 21(3):231-4. PubMed ID: 6364312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of leukocyte aggregation, leukocyte migration and skin reactivity to recall antigens in patients with AIDS.
    Rouveix B; Groult F; Pocidalo JJ
    Clin Exp Immunol; 1986 Dec; 66(3):574-81. PubMed ID: 3568448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations of leucocyte migration activating factor with interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha in drug allergy].
    Sano N; Uno K
    Arerugi; 1998 Nov; 47(11):1198-204. PubMed ID: 9893337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukocyte migration inhibition in methotrexate-induced pneumonitis. Evidence for an immunologic cell-mediated mechanism.
    Akoun GM; Gauthier-Rahman S; Mayaud CM; Touboul JL; Denis MF
    Chest; 1987 Jan; 91(1):96-9. PubMed ID: 3539547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced pneumonitis].
    Kondo A
    Kekkaku; 1999 Jan; 74(1):33-41. PubMed ID: 10067054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the pathogenic mechanism of hypersensitivity to antibacterial agents--correlations of leucocyte migration activating factor and leucocyte migration inhibitory factor with interleukin-2 and interferon-gamma].
    Uno K
    Arerugi; 1993 May; 42(5):656-64. PubMed ID: 8323465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The leukocyte migration inhibition reaction in children with neurodermatitis].
    Gorlanov IA
    Vestn Dermatol Venerol; 1989; (8):35-8. PubMed ID: 2816029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibition factor (MIF) in drug eruption.
    Halevy S; Grunwald MH; Sandbank M; Buimovice B; Joshua H; Livni E
    Arch Dermatol; 1990 Jan; 126(1):48-51. PubMed ID: 2136987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.